Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

EndoV Inhibitors

EndoV inhibitors are a class of small molecules that target and inhibit the enzyme Endonuclease V (EndoV), which plays a crucial role in DNA repair processes. These inhibitors are primarily designed for research purposes and have garnered significant attention in the field of molecular biology and genomics due to their ability to modulate DNA repair mechanisms. EndoV is an endonuclease enzyme found in various organisms, including bacteria and certain archaea. Its primary function is to participate in the base excision repair (BER) pathway, which is responsible for repairing damaged DNA bases. In the context of this repair mechanism, EndoV specifically recognizes and cleaves DNA at sites where deaminated adenine (hypoxanthine) is present in the DNA strand. This cleavage is a critical step in the removal of damaged DNA bases to facilitate the subsequent repair of the DNA strand.

EndoV inhibitors are synthesized to interfere with the enzymatic activity of EndoV, preventing it from recognizing and cleaving the deaminated adenine sites in DNA. These inhibitors are valuable tools in molecular biology research, as they allow scientists to study the effects of impairing the BER pathway and disrupting specific DNA repair processes. Understanding the role of EndoV and its inhibition can provide insights into the broader context of DNA repair mechanisms, mutagenesis, and genome stability. Researchers use EndoV inhibitors to investigate the consequences of EndoV dysfunction in cells and organisms, shedding light on the intricate molecular pathways that maintain DNA integrity. Additionally, these inhibitors can be employed in studies aimed at elucidating the biochemical and structural aspects of EndoV and its interactions with DNA, contributing to a deeper understanding of DNA repair mechanisms at the molecular level.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Inhibits FBL13 by modulating protein ubiquitination.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

Targets FBL13, altering its substrate binding activity.

Pomalidomide

19171-19-8sc-364593
sc-364593A
sc-364593B
sc-364593C
sc-364593D
sc-364593E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$100.00
$143.00
$312.00
$468.00
$1248.00
$1997.00
1
(1)

Modulates FBL13-mediated protein degradation pathways.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Blocks FBL13 activity by inhibiting proteasome function.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

Suppresses FBL13 by inhibiting the NEDDylation process.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Inhibits FBL13 through proteasome inhibition.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$62.00
$225.00
$779.00
24
(1)

Disrupts the FBL13-p53 interaction, stabilizing p53.

(–)-Nutlin-3

675576-98-4sc-222086
sc-222086A
1 mg
5 mg
$122.00
$219.00
2
(1)

Similar to Nutlin-3, it targets FBL13-p53 interaction.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Regulates FBL13-related protein degradation.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

Blocks FBL13 via proteasome inhibition.